| Name | Title | Contact Details |
|---|
InB Biotechnologies Inc is a Newark, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Entasis Therapeutics was established in 2015 with $40 million in start-up funding from AstraZeneca, and all rights to AstraZeneca`s industry-leading discovery and early development small-molecule anti-infectives portfolio. Entasis Therapeutics is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases.
OPK Biotech is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Intellia Therapeutics was formed in 2014 to develop curative medicines, utilizing the promise of the CRISPR/Cas9 technology. Intellia holds exclusive access to one of the broadest intellectual property platforms available for the therapeutic use of CRISPR/Cas9. Intellia is backed by Atlas Venture and Novartis Institutes for Biomedical Research. In January of this year, Intellia Therapeutics announced a large partnering deal with Novartis for CAR-T and HSC applications of the technology.
Arcutis Pharmaceuticals is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.